(Q37594931)

21 August 2017

Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial (English)

1 reference

21 August 2017

1 reference

Alan R Kristal

14

0 references

author name string

Douglas K Price

1

1 reference

21 August 2017

Cindy H Chau

2

1 reference

21 August 2017

Cathee Till

3

1 reference

21 August 2017

Phyllis J Goodman

4

1 reference

21 August 2017

Caitlin E Baum

5

1 reference

21 August 2017

Sandy B Ockers

6

1 reference

21 August 2017

Bevin C English

7

1 reference

21 August 2017

Lori Minasian

8

1 reference

21 August 2017

Howard L Parnes

9

1 reference

21 August 2017

Ann W Hsing

10

1 reference

21 August 2017

Juergen K V Reichardt

11

1 reference

21 August 2017

Ashraful Hoque

12

1 reference

21 August 2017

Catherine M Tangen

13

1 reference

21 August 2017

Ian M Thompson

15

1 reference

21 August 2017

William D Figg

16

1 reference

21 August 2017

language of work or name

English

0 references

publication date

16 October 2010

1 reference

21 August 2017

1 reference

21 August 2017

184

1 reference

21 August 2017

6

1 reference

21 August 2017

2297-2302

1 reference

21 August 2017

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Phenotypic heterogeneity of mutations in androgen receptor gene

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Human prostate cancer risk factors

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

The influence of finasteride on the development of prostate cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Prostate cancer susceptibility genes: lessons learned and challenges posed

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Androgen receptor CAG repeats and prostate cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Androgen-regulated gene expression in prostate cancer

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Design of the Prostate Cancer Prevention Trial (PCPT).

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Association between estrogen and androgen receptor genes and prostate cancer risk.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Role of an androgen receptor gene polymorphism in development of hormone refractory prostate cancer in Indian population.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Association between hormonal genetic polymorphisms and early-onset prostate cancer

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930175

The role of an androgen receptor polymorphism in the clinical outcome of patients with metastatic prostate cancer

3 December 2018

1 reference

12 December 2020

Is the androgen receptor CAG repeat length significant for prostate cancer?

1 reference

12 December 2020

Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population

1 reference

12 December 2020

Re: Prostate cancer and the androgen receptor

1 reference

12 December 2020

Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset

1 reference

12 December 2020

10.1016/J.JURO.2010.08.005

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

1 reference